Loading...
Found 48 Lung Cancer trials
A listing of Lung Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
- Sort by
- Last updated
This study's primary objective will be to create a database of lung cancer patients treated with immunotherapy agents and to access Remnant (left-over) tissue collected from clinically-indicated procedures/surgery for analyses, to determine factors that predict response to immunotherapy, and/or the toxicity prole of patients treated with immunotherapy.
This study investigates non-squamous non-small cell lung cancer. It focuses on patients with advanced or metastatic forms of this condition who have previously been treated and do not have actionable genomic alterations.The study evaluates the effectiveness and tolerability of an investigational medication compared to standard care. It also involves an …
This study investigates high-risk stage I non-small cell lung cancer. The purpose of this study is to evaluate treatment options for patients who have had their cancer completely removed through surgery.The study focuses on evaluating the safety and effectiveness of different treatment options for preventing cancer recurrence. It assesses the …
This study investigates the effect of adding radiation therapy to the usual maintenance therapy with an investigational medication in patients with extensive stage small cell lung cancer. This study aims to compare the progression-free survival and overall survival of patients receiving the investigational medication alone versus those receiving it with …
This study investigates the safety and effectiveness of an investigational antibody-drug conjugate in combination with an immune checkpoint inhibitor, with or without carboplatin, for individuals with extensive stage small cell lung cancer (ES-SCLC). The purpose of this study is to explore how these treatments work together in the first-line setting, …
This study investigates the safety, tolerability, and preliminary effectiveness of an investigational medication, either alone or in combination with another treatment, for patients with advanced solid tumors. The study includes patients with specific types of cancer, such as urothelial cancer and non-small cell lung cancer, who have not responded to …
This study investigates the treatment of KRAS-mutated cancers. The purpose of this study is to evaluate the safety and preliminary effectiveness of a new investigational treatment in patients with specific types of cancer that have a KRAS mutation.The study focuses on assessing the safety and how well the investigational treatment …
Identification of actionable genetic alterations is critical to determining the appropriate therapy in unresectable non-small cell lung cancer (NSCLC). Red blood cells (RBCs) may be an abundant and long-lasting reservoir of detectable tumor DNA. A "liquid biopsy," using blood samples from patients with advanced NSCLC to identify targetable mutations from …
This study investigates the effects of an investigational medication on patients with advanced solid tumors that have a KRAS G12D mutation. The purpose is to understand the safety and effectiveness of the investigational medication when used alone and in combination with other treatments.Participants in the study will receive the investigational …
This study investigates the safety and clinical activity of an investigational medication in participants with advanced solid tumors that have a specific genetic mutation known as KRAS G12C. The purpose of this study is to evaluate how the investigational medication works in different phases, including dose escalation and expansion, to …
Please choose between Voice or SMS based delivery of verification code
or